Fremkalt respons-undersøkelser i klinisk diagnostikk 960

Tidsskrift for den Norske Laegeforening

Volumn 133, Issue 8, 2013, Pages 960-965

  Sand, Trond ^a,b   Kvaløy, Marie Bu ^c   Wader, Tony ^a   Hovdal, Harald ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Stavanger universitetssjukehus   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COMA; DEMYELINATING DISEASE; EVOKED RESPONSE; HUMAN; METHODOLOGY; OPTIC NEURITIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PHYSIOLOGY; REVIEW;

COMA; DEMYELINATING DISEASES; EVOKED POTENTIALS; HUMANS; MONITORING, INTRAOPERATIVE; OPTIC NEURITIS;

MLCS; MLOWN;

EID: 84877685645     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.12.1176     Document Type: Article

References (35)

1. Walsh P, Kane N, Butler S. The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry 2005; 76 (suppl 2): ii16 - 22.
2. Chiappa KH. Evoked potentials in clinical medicine. 3 utg. New York, NY: Raven Press, 1999.
3. Marmor MF, Fulton AB, Holder GE et al. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 2009; 118: 69 - 77.
4. Wassermann EM, Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther 2012; 133: 98 - 107.
5. Chen R, Cros D, Curra A et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 2008; 119: 504 - 32.
6. Michler RP, Unsgård G, Rossvoll I. Nevrofysiologisk monitorering under kirurgi. Tidsskr Nor Legeforen 2013; 133: 306 - 11.
7. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007; 118: 2128 - 48.
8. Guérit JM. Neurophysiological patterns of vegetative and minimally conscious states. Neuropsychol Rehabil 2005; 15: 357 - 71.
9. Duncan CC, Barry RJ, Connolly JF et al. Eventrelated potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin Neurophysiol 2009; 120: 1883 - 908.
10. Cruccu G, Aminoff MJ, Curio G et al. Recommendations for the clinical use of somatosensoryevoked potentials. Clin Neurophysiol 2008; 119: 1705 - 19.
11. Cruccu G, Sommer C, Anand P et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010; 17: 1010 - 8.
12. Wijdicks EF, Hijdra A, Young GB et al. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 67: 203 - 10.
13. Guérit JM. Neurophysiological testing in neurocritical care. Curr Opin Crit Care 2010; 16: 98 - 104.
14. Tiainen M, Kovala TT, Takkunen OS et al. Somatosensory and brainstem auditory evoked potentials in cardiac arrest patients treated with hypothermia. Crit Care Med 2005; 33: 1736 - 40.
15. Guérit JM, Amantini A, Amodio P et al. Consensus on the use of neurophysiological tests in the intensive care unit (ICU): electroencephalogram (EEG), evoked potentials (EP), and electroneuromyography (ENMG). Neurophysiol Clin 2009; 39: 71 - 83.
16. Abend NS, Licht DJ. Predicting outcome in children with hypoxic ischemic encephalopathy. Pediatr Crit Care Med 2008; 9: 32 - 9.
17. Carrai R, Grippo A, Lori S et al. Prognostic value of somatosensory evoked potentials in comatose children: a systematic literature review. Intensive Care Med 2010; 36: 1112 - 26.
18. Houlden DA, Taylor AB, Feinstein A et al. Early somatosensory evoked potential grades in comatose traumatic brain injury patients predict cognitive and functional outcome. Crit Care Med 2010; 38: 167 - 74.
19. Su YY, Xiao SY, Haupt WF et al. Parameters and grading of evoked potentials: prediction of unfavorable outcome in patients with severe stroke. J Clin Neurophysiol 2010; 27: 25 - 9.
20. Haupt WF, Pawlik G, Thiel A. Initial and serial evoked potentials in cerebrovascular critical care patients. J Clin Neurophysiol 2006; 23: 389 - 94.
21. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227 - 31.
22. Polman CH, Reingold SC, Banwell B et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292 - 302.
23. Pau D, Al Zubidi N, Yalamanchili S et al. Optic neuritis. Eye (Lond) 2011; 25: 833 - 42.
24. Neto SP, Alvarenga RM, Vasconcelos CC et al. Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica. Mult Scler 2013; 19: 173 - 8.
25. Gronseth GS, Ashman EJ. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 1720 - 5.
26. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121 - 7.
27. Poser CM, Brinar VV. Diagnostic criteria for multiple sclerosis. Clin Neurol Neurosurg 2001; 103: 1 - 11.
28. Miller DH, Weinshenker BG, Filippi M et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008; 14: 1157 - 74.
29. Sand T, Stovner LJ, Rinck PA et al. Laboratoriediagnostikk ved multippel skelerose. Tidsskr Nor Lægeforen 1991; 111: 2267 - 70.
30. Sand T, Sulg IA. Evoked potentials and CSF-immunoglobulins in MS: relationship to disease duration, disability, and functional status. Acta Neurol Scand 1990; 82: 217 - 21.
31. Leocani L, Rovaris M, Boneschi FM et al. Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study. J Neurol Neurosurg Psychiatry 2006; 77: 1030 - 5.
32. Pelayo R, Montalban X, Minoves T et al. Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? Mult Scler 2010; 16: 55 - 61.
33. Schlaeger R, D'Souza M, Schindler C et al. Prediction of long-term disability in multiple sclerosis. Mult Scler 2012; 18: 31 - 8.
34. Todnem K, Sand T, red. Retningslinjer for metoder i klinisk nevrofysiologi. Del 2. Skriftserie for leger. Oslo: Den norske legeforening, 2004.
35. Sand T, red. Retningslinjer for metoder i klinisk nevrofysiologi. Del 1. 2.utg. Skriftserie for leger. Oslo: Den norske legeforening, 2008.